FindTrial
Sign In

Expression of TSP-1 and TGF-beta and their association with severity in patients of premature coronary artery disease.

Expression of Thrombospondin-1(TSP-1) and transforming Growth factor-beta (TGF-beta) and their association with severity in patients of premature coronary artery disease. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/075792
Enrollment
90
Registered
2024-10-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I213- ST elevation (STEMI) myocardial infarction of unspecified site

Interventions

Intervention1: NIL: NIL

Sponsors

Govind Ballabh Pant Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed as STEMI (ST elevation Myocardial Infarction) as per study by Karlowicz et al.

Exclusion criteria

Exclusion criteria: 1. Any previous cardiac disease or cardiac surgery 2. Any Malignancy 3. hematopoietic disorders 4. Diabetes 5. Known case of autoimmune disease 6. Pregnant and Lactating females

Design outcomes

Primary

MeasureTime frame
Regulation of gene TSP-1 and TGF-Beta in premature coronary artery diseaseTimepoint: 1 year—

Secondary

MeasureTime frame
levels of TSP-1(ng/mL) and TGF-beta(pg/mL) in premature coronary artery diseaseTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Cheteny

G B Pant Institute of Post Graduate Medical Education and Research (GIPMER)

10197cheteny@gmail.com8750102573

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026